AnaptysBio, Inc. (ANAB)
46.21
+0.53
(+1.16%)
USD |
NASDAQ |
Jan 20, 16:00
46.16
-0.05
(-0.11%)
After-Hours: 20:00
AnaptysBio Free Cash Flow: -145.42M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals, Inc. | -82.95M |
| Ovid Therapeutics, Inc. | -37.93M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| CorMedix, Inc. | 74.42M |
| Verastem, Inc. | -140.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.36M |
| Cash from Investing (Quarterly) | 103.28M |
| Cash from Financing (Quarterly) | -10.39M |
| Free Cash Flow Per Share (Quarterly) | -0.9431 |
| Free Cash Flow to Equity (Quarterly) | -27.36M |
| Free Cash Flow to Firm (Quarterly) | -4.853M |
| Free Cash Flow Yield | -10.59% |